Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Technology services tags : Therapy save search
Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 2.03%
H: 3.98%
C: -8.76%
beyond tumors positive cancer immunotherapy meeting therapy
Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice
Published: 2023-10-17 (Crawled : 12:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 0.45%
H: 11.11%
C: 8.0%
pre-clinical beyond tumor therapy
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 2.68%
H: 0.43%
C: -2.61%
conference beyond positive cancer international preclinical therapeutics therapy molecular
Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-04 (Crawled : 12:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 0.95%
H: 3.76%
C: 0.94%
conference beyond cancer international program therapeutics therapy molecular
Beyond Cancer™ to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting
Published: 2023-09-27 (Crawled : 13:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 2.37%
H: 1.15%
C: -3.47%
beyond meeting therapy
Occupational Therapy Software Market to grow by USD 87,435.59 thousand between 2022 to 2027; Growth opportunities led by Axis Teletherapy and Baylaan Technologies Inc- Technavio
Published: 2023-06-29 (Crawled : 22:00) - prnewswire.com
GPN | $122.1 -0.07% 0.0% 1.1M
|
Technology Services
|
| O: 1.23%
H: 1.34%
C: 0.37%
software therapy growth market
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the American Association for Cancer Research (AACR) 2023 Annual Meeting
Published: 2023-04-19 (Crawled : 13:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: -0.65%
H: 2.45%
C: -2.29%
beyond association tumors positive cancer research preclinical meeting therapy
Beyond Cancer™ to Present Two Posters for Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2023 AACR Annual Meeting
Published: 2023-03-14 (Crawled : 22:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: -0.59%
H: 1.63%
C: -4.0%
meeting therapy
iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023Company is exploring strategic options for its Therapy business line
Published: 2023-03-13 (Crawled : 14:00) - biospace.com/
ICAD | $1.54 -3.15% -3.25% 68K
|
Technology Services
|
| O: -3.77%
H: 0.47%
C: -33.04%
report financial therapy
Market Forecasts for Immuno-Oncology Diagnostics 2023: Sector Represents a Revolution in Cancer Therapy
Published: 2023-01-20 (Crawled : 22:00) - prnewswire.com
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
| Email alert
Add to watchlist
ANPCY | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
| Email alert
Add to watchlist
TXG | $27.92 -3.56% -3.69% 2M
|
Health Technology
| Email alert
Add to watchlist
NVTA | $0.019 0.0% 22M
|
Health Services
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
ANPCF | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
| Email alert
Add to watchlist
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
| Email alert
Add to watchlist
BIOC | $0.4349 -10.32% 750K
|
Health Services
| Email alert
Add to watchlist
NH | $1.35 -46.64% -1.48% 0
|
Technology Services
| Email alert
Add to watchlist
MLAB | $101.19 1.58% 1.55% 27K
|
Health Technology
| Email alert
Add to watchlist
diagnostics therapy cancer market
Rezolute Announces Initiation of a Phase 2 Study of RZ402 in Patients with Diabetic Macular EdemaRZ402 is an oral therapy being developed as a potential alternative to invasive and suboptimal injections into the eye
Published: 2022-12-15 (Crawled : 13:20) - biospace.com/
RZLT 4 | $3.44 4.24% 4.07% 340K
|
Technology Services
|
| O: 0.66%
H: 2.61%
C: -2.61%
rz402 macular eye alternative potential therapy study diabetic
OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands
Published: 2022-09-20 (Crawled : 12:00) - globenewswire.com
OPRX A | $9.3 -0.53% -0.54% 300K
|
Technology Services
|
| O: -0.13%
H: 1.4%
C: 1.14%
partnership brands therapy
Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)
Published: 2022-08-23 (Crawled : 14:00) - biospace.com/
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 1.76%
H: 9.3%
C: 8.22%
air therapy study
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect
Published: 2022-04-11 (Crawled : 16:00) - biospace.com/
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: -2.46%
H: 0.01%
C: -5.63%
research preclinical therapy cancer pre-clinical
Boehringer Ingelheim Selects Veeva Development Cloud Worldwide to Bring Innovative Therapies to Patients Faster
Published: 2022-03-29 (Crawled : 13:00) - biospace.com/
VEEV | $198.38 -0.58% 0.0% 730K
|
Technology Services
|
| O: 1.95%
H: 6.19%
C: 5.59%
cloud therapy
Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 2.38%
H: 6.68%
C: 5.08%
therapy cancer
Positive Study Results Published for KidneyIntelX™ in Monitoring Patient Response to New Drug Therapy
Published: 2022-01-11 (Crawled : 14:00) - biospace.com/
RNLX | $0.785 -2.34% 28K
|
Technology Services
|
| O: 2.98%
H: 0.0%
C: 0.0%
new drug response drug positive therapy
PharmaEssentia Selects Veeva Data Cloud to Support Launch of Novel Therapy for Rare, Chronic Blood Cancers
Published: 2021-12-14 (Crawled : 12:30) - prnewswire.com
VEEV | $198.38 -0.58% 0.0% 730K
|
Technology Services
|
| O: -0.21%
H: 1.22%
C: -1.34%
blood therapy cancer rare
The Center for Breakthrough Medicines Adopts Veeva Vault Quality Suite to Help Advance Cell and Gene Therapy Contract Services
Published: 2021-11-16 (Crawled : 12:00) - prnewswire.com
VEEV | $198.38 -0.58% 0.0% 730K
|
Technology Services
|
| O: -0.69%
H: 1.83%
C: 1.76%
gene therapy therapy contract
Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes
Published: 2021-10-26 (Crawled : 14:00) - globenewswire.com
CERN | $94.92 0.03%
|
Technology Services
|
| O: 0.32%
H: 0.0%
C: 0.0%
therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.